透過您的圖書館登入
IP:18.116.40.177
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

並列摘要


In a patient infected with HIV-1, the presence of latently infected cells from which the virus can be reactivated and rekindle HIV infection in the patient necessitates lifelong administration of antiretroviral treatment. The biology of HIV latency and viral silencing is now becoming clearer at a molecular and cellular level. However, our understanding of HIV-1 latency in vivo is still inadequate. Attempts to therapeutically reactivate the virus in infected patients have yielded disappointing results. This article reviews the research and clinical findings and discusses current thinking on the subject of HIV latency and reactivation.

延伸閱讀


  • (2016). HIV Infection & AIDS. Statistics Of Communicable Diseases and Surveillance Report Republic China, (), 146-152. https://www.airitilibrary.com/Article/Detail?DocID=19924526-201612-201612300007-201612300007-146-152
  • (2020). HIV Infection & AIDS. Statistics Of Communicable Diseases and Surveillance Report Republic China, (), 146-152. https://www.airitilibrary.com/Article/Detail?DocID=19924526-202011-202012110008-202012110008-146-152
  • (2019). HIV Infection & AIDS. Statistics Of Communicable Diseases and Surveillance Report Republic China, (), 145-151. https://www.airitilibrary.com/Article/Detail?DocID=19924526-201911-201911290013-201911290013-145-151
  • (2018). HIV Infection & AIDS. Statistics Of Communicable Diseases and Surveillance Report Republic China, (), 144-150. https://www.airitilibrary.com/Article/Detail?DocID=19924526-201811-201901140005-201901140005-144-150
  • Hsiung, P. C., & Tsai, Y. F. (2000). Stressors of Living with HIV/AIDS: Patients' Perspectives. The Kaohsiung Journal of Medical Sciences, 16(3), 148-155. https://doi.org/10.6452/KJMS.200003.0148